Dynamic Forecasting in the Oncology Environment - Kantar Health
Dynamic Forecasting in the Oncology Environment - Kantar Health
Dynamic Forecasting in the Oncology Environment - Kantar Health
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
The catalyst for<br />
successful decision<br />
mak<strong>in</strong>g <strong>in</strong> <strong>the</strong> life<br />
sciences <strong>in</strong>dustry<br />
Register now!<br />
Enrollment is limited, to ensure a<br />
very <strong>in</strong>teractive session.<br />
Workshop Presenter<br />
Bob Ramsey, Ph.D.<br />
Chief Scientific Officer<br />
Venue<br />
Hyatt Regency Philadelphia<br />
at Penn’s Land<strong>in</strong>g<br />
201 South Columbus Blvd.<br />
Philadelphia, PA 19106<br />
Click for hotel <strong>in</strong>formation<br />
Why <strong>Kantar</strong> <strong>Health</strong>?<br />
A limited block of rooms has been<br />
<strong>Kantar</strong> reserved <strong>Health</strong> at is a a discounted global, evidence-based rate of US<br />
decision $199 per support night. partner This to room <strong>the</strong> world’s rate will<br />
lead<strong>in</strong>g be honored pharmaceutical, through biotech, Aug. 26, device 2013,<br />
and and diagnostic is based companies. on availability. Our 700+ To<br />
staff secure <strong>in</strong> over your 40 accommodations countries act as catalysts,<br />
this<br />
br<strong>in</strong>g<strong>in</strong>g specially toge<strong>the</strong>r discounted cl<strong>in</strong>ical, medical rate, and<br />
methodological click here or expertise, dial +1.888.421.1442<br />
commercial/<br />
market<strong>in</strong>g before Aug. know-how 26, 2013 and proprietary and mention data.<br />
It is this that rare you comb<strong>in</strong>ation, are attend<strong>in</strong>g toge<strong>the</strong>r <strong>Kantar</strong> with<br />
<strong>Health</strong>’s Workshop. The hotel will<br />
our unparalleled stakeholder reach, that<br />
honor this rate for three days preenables<br />
us to mobilize <strong>in</strong>cisive, imag<strong>in</strong>ative<br />
and post-workshop.<br />
and timely ROI-driven solutions,<br />
empower<strong>in</strong>g clients to deliver better<br />
healthcare options to <strong>the</strong>ir customers.<br />
<strong>Dynamic</strong> <strong>Forecast<strong>in</strong>g</strong> <strong>in</strong> <strong>the</strong><br />
<strong>Oncology</strong> <strong>Environment</strong><br />
September 19, 2013 – Philadelphia, PA<br />
<strong>Forecast<strong>in</strong>g</strong> <strong>the</strong> commercial potential <strong>in</strong> oncology markets <strong>in</strong>volves some unique challenges.<br />
Determ<strong>in</strong><strong>in</strong>g <strong>the</strong> appropriate patient populations and <strong>the</strong>ir number requires reliable data sources.<br />
In-depth knowledge of def<strong>in</strong>itions and of treatment paradigms are also important elements.<br />
Address<strong>in</strong>g <strong>the</strong> cascade of patients through l<strong>in</strong>es of <strong>the</strong>rapies is complex. New <strong>the</strong>rapies<br />
address<strong>in</strong>g various biomarkers and patient segments may mean that forecast<strong>in</strong>g a s<strong>in</strong>gle tumor<br />
type may lead to creat<strong>in</strong>g many different forecasts.<br />
Course Agenda<br />
Cancer – How is it treated?<br />
<strong>Oncology</strong> Drug Use<br />
Types and Classes • Changes <strong>in</strong> <strong>the</strong> Use of <strong>Oncology</strong> Products<br />
<strong>Oncology</strong> Market Considerations<br />
Growth vs. O<strong>the</strong>r Therapeutic Areas • Small Molecule Approval vs. Biologics<br />
Growth of Targeted Therapies • History of Drug Approvals (US) • Major Competitors<br />
Emerg<strong>in</strong>g Competitors • Lead<strong>in</strong>g Products<br />
<strong>Oncology</strong> Research & Development<br />
Overview of Phase III Products • Up and Com<strong>in</strong>g Targets<br />
Major Pharma Precl<strong>in</strong>ical -- Phase II Pipel<strong>in</strong>es<br />
<strong>Oncology</strong> Lifecycle Development<br />
<strong>Oncology</strong> Epidemiology<br />
US Data Sources • Ex-US Data Sources • Effects of Chang<strong>in</strong>g Demographics<br />
Age-Adjusted Incidence Rates • Sources and Calculation of Recurrence Data<br />
Patient Population Outputs<br />
Impact of Biomarkers on Target Population Def<strong>in</strong>ition<br />
<strong>Oncology</strong> Model<strong>in</strong>g Considerations<br />
Cross-sectional vs. Patient Flow Model<strong>in</strong>g<br />
<strong>Oncology</strong> <strong>Forecast<strong>in</strong>g</strong> Process<br />
Relevant Patient Populations • Present and Future Competitive Set<br />
Market Penetration • Duration of Therapy<br />
<strong>Forecast<strong>in</strong>g</strong> Extended Use<br />
Workshop Coord<strong>in</strong>ator<br />
L<strong>in</strong>da Morgan<br />
Tel: +1.816.285.1610<br />
Fax: +1.816.285.1660<br />
l<strong>in</strong>da.morgan@kantarhealth.com<br />
www.kantarhealth.com
REGISTRATION FORM<br />
<strong>Dynamic</strong> <strong>Forecast<strong>in</strong>g</strong> <strong>in</strong> <strong>the</strong> <strong>Oncology</strong> <strong>Environment</strong> Workshop<br />
September 19, 2013<br />
Philadelphia, PA<br />
Name<br />
Title<br />
Company<br />
Address<br />
City/State/Country<br />
Zip Code<br />
Telephone<br />
Fax<br />
E-mail (required)<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
How did you learn<br />
about workshop? Email Direct Mail Colleague Advertisement<br />
Registration<br />
Fee<br />
Payment<br />
Method<br />
$700 USD<br />
American Express MasterCard VISA<br />
Credit Card #:<br />
Expiration Date:<br />
Pr<strong>in</strong>t Name<br />
(as shown on card)<br />
Signature<br />
______________________________________________________________________________________<br />
________________<br />
Amount<br />
Authorized<br />
_____________________________________________________<br />
______________________________________________________________________________________<br />
______________________________________________________________________________________<br />
Email L<strong>in</strong>da Morgan or fax <strong>the</strong> completed form to +1.816.285.1660.<br />
Workshop Fee: US $700<br />
Includes course, handbook, cont<strong>in</strong>ental breakfast, lunch and refreshments.<br />
<strong>Kantar</strong> <strong>Health</strong> does not provide refunds for cancellations. The registration fee may be applied to a future <strong>Kantar</strong> <strong>Health</strong> Sem<strong>in</strong>ar for you or ano<strong>the</strong>r member of your<br />
organization. Your notice of cancellation must be received <strong>in</strong> writ<strong>in</strong>g (by letter, fax, or email). No credits will be issued for those who do not attend <strong>the</strong> scheduled course<br />
and/or cancel less than two work<strong>in</strong>g days before <strong>the</strong> start of <strong>the</strong> sem<strong>in</strong>ar. In <strong>the</strong> event of a sem<strong>in</strong>ar cancellation, <strong>Kantar</strong> <strong>Health</strong> assumes no liability for non-refundable<br />
transportation costs, hotel accommodations, or additional costs <strong>in</strong>curred by registrants. This event is offered to our pharmaceutical clients and colleagues. We reserve <strong>the</strong><br />
right to exclude <strong>in</strong>dividuals who we validate as be<strong>in</strong>g competitors.